The bill (Reg. No. 7146) defines the
term "adulterated medicine" and establishes criminal and administrative
responsibility for production and sale of adulterated medicine.
Under the bill, adulterated medicine "is the medicine produced with the violation of the set requirements in part of incongruence between the actual contents of ingredients and the label, or the contents of ingredients in the inadequate composition, absence or lack of active agents, and/or medicine that fail to comply with the set requirements for the packaging, including illegal use of the brand for goods and services, imitation of the form, package or shaping of wares of another producer, and the medicine produced by the manufacturer other than the one stated in the registration certificate."
The committee members suggest the following ways of effecting governance in the sphere of medicine circulation:
registration, certification and standardization of medicine;
licensing, certification and fixing a quota for particular types of activity in the sphere of medicine circulation;
official evaluation and certification of the personnel employed in the sphere of medicine circulation;
control over the production, manufacture, quality, safety, transportation, sale, terms of sale, utilization and liquidation of medicine.